FDA warns against widely used ovarian cancer screening test
WASHINGTON — The Food and Drug Administration on Wednesday warned women and their doctors that current screening tests for ovarian cancer are unreliable and could lead to false diagnoses.
In a statement, the FDA said it was “especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increase risk of ovarian cancer.”
Ovarian cancer is the fifth-leading cause of cancer-related deaths among women. The National Cancer Institute estimates that this year more than 22,000 women between ages 35 and 74 will be diagnosed with the disease.
Recent Posts
